Close



Feb 13, 2024 07:00AM
Nov 13, 2023 07:00AM
Nov 10, 2023 08:03AM
Nov 10, 2023 08:00AM
Aug 14, 2023 07:00AM
Jul 11, 2023 08:00AM
Jun 28, 2023 08:57AM UPDATE -- Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update
Jun 28, 2023 07:00AM
May 16, 2023 07:02AM
May 16, 2023 07:00AM
Mar 15, 2023 07:46AM
Mar 15, 2023 07:45AM
Mar 15, 2023 07:45AM
Mar 15, 2023 07:45AM Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old
Feb 22, 2023 06:52AM
Feb 21, 2023 08:32PM
Feb 21, 2023 08:32PM
Nov 14, 2022 07:00AM
Nov 14, 2022 07:00AM
Aug 15, 2022 07:00AM
Aug 15, 2022 07:00AM Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update
Jun 28, 2022 06:11AM
Jun 28, 2022 06:10AM
Jun 28, 2022 06:10AM
May 25, 2022 05:59AM
May 24, 2022 08:21AM
May 24, 2022 06:01AM
May 24, 2022 06:00AM FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
May 24, 2022 06:00AM
May 24, 2022 06:00AM
Mar 25, 2022 08:01AM
Feb 14, 2022 07:00AM
Feb 14, 2022 07:00AM
Jan 4, 2022 08:30AM
Nov 15, 2021 07:00AM Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update
Nov 15, 2021 07:00AM
Oct 26, 2021 07:38AM
May 3, 2021 07:01AM

251,613 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All